Differential expression of TcR-CD3 zeta as evidence for altered immunoregulation in preeclamptic versus normotensive women

American Journal of Obstetrics and Gynecology

Volumn 189, Issue 3, 2003, Pages 843-847

  Lam, Garrett K ^a,b   Whitecar, Paul W ^b   Orton, Susan ^a   Boggess, Kim A ^a   Taylor, Douglas D ^c  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b Womack Army Medical Cente ^*  (United States)

^c University of Louisville School of Medicine   (United States)

Author keywords

Preeclampsia; T cell function; TcR CD3 zeta protein

Indexed keywords

CD3 ANTIGEN; CD3 ZETA ANTIGEN; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY CD3 ZETA; PROTEIN SUBUNIT; T LYMPHOCYTE RECEPTOR; UNCLASSIFIED DRUG;

ANTIGEN EXPRESSION; BLOOD SAMPLING; CELL ASSAY; CHEMOLUMINESCENCE; CONFERENCE PAPER; CONTROLLED STUDY; DENSITOMETRY; FEMALE; FLOW CYTOMETRY; GESTATIONAL AGE; HUMAN; HUMAN CELL; IMMUNOASSAY; IMMUNOREGULATION; INTERMETHOD COMPARISON; LEUKEMIA CELL LINE; PREECLAMPSIA; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; STUDENT T TEST; WESTERN BLOTTING;

EID: 0141748146     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1067/S0002-9378(03)00815-9     Document Type: Conference Paper

References (13)

1. Dekker GA, Robillard PY, Hulsey TC. Immune maladaptation in the etiology of preeclampsia: a review of corroborative epidemiologic studies. Obstet Gynecol Surv 1998;53:377-82.
2. Mackay AP, Berg CJ, Atrash HK. Pregnancy-related mortality from preeclampsia and eclampsia. Obstet Gynecol 2001;97:533-8.
3. Luft BJ, Remington JS. Effect of pregnancy on augmentation of natural killer cell activity by Corynebacterium parvum and Toxoplasma gondii. J Immunol 1984;132:2375-80.
4. Bedenicki I, Newton DJ, Flanagan BF, Johnson PM, Rukavina D, Chrstmas SE. Human decidualized endometrial T lymphocytes do not substantially down-regulate CD3-zeta. Am J Reprod Immunol 1999;41:245-52.
5. Taylor DD, Sullivan SA, Eblen AC, Gercel-Taylor C. Modulation of T-cell CD3-zeta chain expression during normal pregnancy. J Reprod Immunol 2002;54:15-31.
6. Redman CWG, Sacks GP, Sargent IL. Preeclampsia: an excessive maternal inflammatory response to pregnancy. Am J Obstet Gynecol 1999;180:499-506.
7. Saito S, Umekage H, Sakamoto Y, Sakai M, Tanebe K, Sasaki Y, et al. Increased T-helper-1-type immunity and decreased T-helper-2-type immunity in patients with pre-eclampsia. Am J Reprod Immunol 1999;41:297-306.
8. Sunder-Plassmann G, Derfler K, Wagner L, Stockenhuber F, Ender M, Nowotny C, et al. Increased serum activity of interleukin-2 in patients with pre-eclampsia. J Autoimmun 1989;2:203-5.
9. Whitecar PW, Boggess KA, McMahon MJ, Thorp JM, Taylor DD. Altered expression of TcR/CD3ζ induced by sera from women with preeclampsia. Am J Obstet Gynecol 2001;185:812-81.
10. National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. Report of the national high blood pressure education program working group on high blood pressure in pregnancy. Am J Obstet Gynecol 2000;180:S1-22.
11. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (Lond) 1970;227:680-5.
12. Brown R, Clugston C, Burns P, Edlin A, Vasey P, Vojtesek B, et al. Increased accumulation of p53 protein in cisplatin-resistant ovarian cell lines. Int J Cancer 1993;55:678-84.
13. Mosmann TR, Cherwinski H, Bond MW. Two types of murine helper T cell clone I: definition according to profiles of lymphokine activities and secreted proteins. J Immunol 1986;136:2348-57.